Patient living with hereditary ATTR Amyloidosis

Описание к видео Patient living with hereditary ATTR Amyloidosis

Rick, a man in his 60's, talks about living with the rare disease, hereditary ATTR amyloidosis, a rapidly progressive and life-threatening disease, and finding new hope in Alnylam's new treatment, ONPATTRO™ which has just been approved by the FDA in August 2018.

Visit www.hpr.fm for more health-related stories and interviews.

Комментарии

Информация по комментариям в разработке